Literature DB >> 16306339

Type 1 and type 2 diabetes: what do they have in common?

Tiinamaija Tuomi1.   

Abstract

Type 1 and type 2 diabetes frequently co-occur in the same families, suggesting common genetic susceptibility. Such mixed family history is associated with an intermediate phenotype of diabetes: insulin resistance and cardiovascular complications in type 1 diabetic patients and lower BMI and less cardiovascular complications as well as lower C-peptide concentrations in type 2 diabetic patients. GAD antibody positivity is more common in type 2 diabetic patients from mixed families than from common type 2 diabetes families. The mixed family history is associated with more type 1-like genetic (HLA and insulin gene) and phenotypic characteristics in type 2 diabetic patients, especially in the GAD antibody-positive subgroup. Leaving out the extreme ends of diabetes phenotypes, young children progressing rapidly to total insulin deficiency and strongly insulin-resistant subjects mostly with non-Europid ethnic origin, a large proportion of diabetic patients may have both type 1 and type 2 processes contributing to their diabetic phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306339     DOI: 10.2337/diabetes.54.suppl_2.s40

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.

Authors:  Milca Asanghanwa; Frans K Gorus; Ilse Weets; Bart V der Auwera; Folefac Aminkeng; Eric Mbunwe; Patrick Goubert; Katrijn Verhaeghen; Eugene Sobngwi; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Bart Keymeulen; Jean-Claude N Mbanya; Chris van Schravendijk
Journal:  Diabetes Res Clin Pract       Date:  2013-11-20       Impact factor: 5.602

2.  Differential Expression of Metabolism-related Genes in Liver of Diabetic Obese Rats.

Authors:  Eunhui Seo; Eun-Jin Park; Mi-Kyoung Park; Duk Kyu Kim; Hye-Jeong Lee; Sook-Hee Hong
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

3.  HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients.

Authors:  Mariana Fernández; Matías Fabregat; Gerardo Javiel; Adriana Mimbacas
Journal:  World J Diabetes       Date:  2014-10-15

Review 4.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

5.  Risk Factors for Type 1 Diabetes Mellitus among Children and Adolescents in Basrah.

Authors:  Athar Abdul Samad Majeed; Kadhum Hassan
Journal:  Oman Med J       Date:  2011-05

Review 6.  Genetically modified pigs for biomedical research.

Authors:  Yonglun Luo; Lin Lin; Lars Bolund; Thomas G Jensen; Charlotte Brandt Sørensen
Journal:  J Inherit Metab Dis       Date:  2012-03-28       Impact factor: 4.982

Review 7.  The role of Müller cell glucocorticoid signaling in diabetic retinopathy.

Authors:  Farhad Ghaseminejad; Lew Kaplan; Anna M Pfaller; Stefanie M Hauck; Antje Grosche
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-16       Impact factor: 3.117

8.  Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project.

Authors:  Humberto Parada; Rebecca J Cleveland; Kari E North; June Stevens; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Maria E Martinez; Marilie D Gammon
Journal:  Mol Carcinog       Date:  2018-12-11       Impact factor: 4.784

9.  Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs.

Authors:  Kazuhiro Umeyama; Masahito Watanabe; Hitoshi Saito; Mayuko Kurome; Sadaaki Tohi; Hitomi Matsunari; Keizaburo Miki; Hiroshi Nagashima
Journal:  Transgenic Res       Date:  2009-04-09       Impact factor: 2.788

Review 10.  Type 1 diabetes.

Authors:  Mark A Atkinson; George S Eisenbarth; Aaron W Michels
Journal:  Lancet       Date:  2013-07-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.